Jon Mark Hirshon, MD, MPH, PhD, is the principal investigator of “Wound Fluid as Regulator for Extracellular Matrix Remodeling and Recurrence in Inflammatory Breast Cancer,” a study funded by the Fogarty International Center at NIH in the amount of $322,060. The purpose of this project is to seek biological factors in wound fluid that foster dissemination of carcinoma cells throughout the body, making the disease resistant to radiation and chemotherapy. The research will be conducted by faculty members at Cairo University and Ain Shams University in Egypt, working in collaboration with Dr. Hirshon as well as colleagues at MD Anderson Cancer Center in Houston. The study period began in September 2017 and extends to mid-2019.